Humana Inc. Reports $40,000 in Q1 2025 Lobbying Activities

Humana Inc. recently disclosed $40,000 in lobbying expenditures for the first quarter of 2025, according to a new filing under the Lobbying Disclosure Act.

This lobbying effort focused on issues such as:

“Matters pertaining to Medicare Advantage and VA coverage, including care coordination and other aspects regarding veterans’ choices among various government insurance options.”

You can find additional data on corporate lobbying at Quiver Quantitative.

Congressional Trading of Humana Stock

In the last six months, members of Congress have traded Humana stock ($HUM) on two occasions. Both transactions were purchases, with no sales recorded.

Here is a breakdown of the recent trading of $HUM stock by Congress members over the past six months:

To monitor congressional stock trading, visit Quiver Quantitative’s congressional trading dashboard.

Insider Trading Activity at Humana

In the past six months, Humana insiders have engaged in one open market transaction involving $HUM stock. This transaction consisted of a single sale with no purchases.

Here’s a summary of the recent trading of $HUM stock by insiders during this period:

• TIMOTHY S. HUVAL (Chief Administrative Officer) sold 3,703 shares for an estimated $948,925.

For insights on insider transactions, check out Quiver Quantitative’s insider trading dashboard.

Hedge Fund Activity Involving Humana Stock

This recent quarter saw 376 institutional investors increase their shares in Humana, while 545 reduced their holdings.

Below are some of the most significant recent changes:

• DODGE & COX added 5,264,045 shares (+106.7%) in Q4 2024, valued at approximately $1,335,540,856.
• WELLINGTON MANAGEMENT GROUP LLP reduced their position by 2,020,721 shares (-44.0%) in Q4 2024, amounting to an estimated $512,677,124.
• VANGUARD GROUP INC added 1,751,857 shares (+15.8%) in Q4 2024, valued at around $444,463,639.
• PZENA INVESTMENT MANAGEMENT LLC increased their holdings by 1,103,132 shares (+44.0%) in Q4 2024, valued at an estimated $279,875,619.
• BOSTON PARTNERS added 893,637 shares (+435.8%), valued at about $226,724,643, in Q4 2024.
• SESSA CAPITAL IM, L.P. increased their position by 827,619 shares (+inf%) in Q4 2024, valued at approximately $209,975,216.
• CITADEL ADVISORS LLC added 789,227 shares (+152.5%) in Q4 2024, valued at around $200,234,782.

To follow hedge fund stock portfolios, visit Quiver Quantitative’s institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative’s disclaimers for additional information.

This article was originally published on Quiver News; read the full story.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.